Last 4,943 INR
Change Today +46.00 / 0.94%
Volume 4.2K
SKB On Other Exchanges
Symbol
Exchange
Natl India
As of 5:03 AM 08/21/14 All times are local (Market data is delayed by at least 15 minutes).

glaxosmithkline consumer hea (SKB) Snapshot

Open
4,930
Previous Close
4,897
Day High
4,949
Day Low
4,880
52 Week High
08/5/14 - 4,996
52 Week Low
09/3/13 - 3,801
Market Cap
207.7B
Average Volume 10 Days
11.1K
EPS TTM
--
Shares Outstanding
42.1M
EX-Date
07/28/14
P/E TM
--
Dividend
45.00
Dividend Yield
0.91%
Current Stock Chart for GLAXOSMITHKLINE CONSUMER HEA (SKB)

Related News

No related news articles were found.

glaxosmithkline consumer hea (SKB) Related Businessweek News

No Related Businessweek News Found

glaxosmithkline consumer hea (SKB) Details

GlaxoSmithKline Consumer Healthcare Limited operates in the health food drinks industry in India. It manufactures and markets health food drinks, nutritional supplements, biscuits, and choco-malt drinks under the Horlicks, Boost, Maltova, and Viva brand names. The company also offers over-the-counter medicine, including Crocin, a pain and body ache relieving drug; Crocin Pain Relief, a pain relief medicine; Crocin Cold and Flu, which provides relief from cold; and Crocin paediatric medicines for infants, toddlers, and older kids up to 12 years. In addition, it provides Eno, an antacid for acidity, gastric discomfort, and heat burn; and Iodex for head, neck, back joint, and muscular pains, as well as Iodex creams and gels; and oral care products under the Sensodyne brand name. The company exports its products to Pakistan, Myanmar, Sri Lanka, Bangladesh, the Middle East, Nepal, Kenya, and Malaysia. GlaxoSmithKline Consumer Healthcare Limited was incorporated in 1958 and is headquartered in Gurgaon, India.

3,502 Employees
Last Reported Date: 07/11/14
Founded in 1958

glaxosmithkline consumer hea (SKB) Top Compensated Officers

Managing Director, Executive Director and Mem...
Total Annual Compensation: 97.4M
Director of Finance, Wholetime Director, Memb...
Total Annual Compensation: 36.7M
Director of Operations, Wholetime Director an...
Total Annual Compensation: 36.4M
Compensation as of Fiscal Year 2014.

glaxosmithkline consumer hea (SKB) Key Developments

GlaxoSmithkline Consumer Healthcare Ltd Announces Board Changes

GlaxoSmithkline Consumer Healthcare Ltd. announced that the Board of Directors of the company at its meeting held on August 06, 2014, on recommendation of the Nomination & Remuneration Committee, appointed Ms. Sangeeta Talwar, as an Independent Director of the company, in the casual vacancy created by the resignation of Ms. Ireena Vlttal.

Glaxosmithkline Consumer Healthcare Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2014

GlaxoSmithKline Consumer Healthcare Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net sales/income from operations of INR 8,529.2 million against INR 8,529.2 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,527.3 million against INR 1,438.4 for the same period a year ago. Profit from ordinary activities before tax was INR 1,983.0 million against INR 1,821.1 million for the same period a year ago. Net profit for the period was INR 1,301.2 million against INR 1,199.6 million for the same period a year ago. Basic and diluted earnings per share (before and after extraordinary items) were INR 30.94 against INR 28.52 per share a year ago.

GlaxoSmithKline Consumer Healthcare Limited to Report Q1, 2015 Results on Aug 06, 2014

GlaxoSmithKline Consumer Healthcare Limited announced that they will report Q1, 2015 results on Aug 06, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SKB:IN 4,943.00 INR +46.00

SKB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arena Pharmaceuticals Inc $4.23 USD 0.00
DC Brands International Inc $0.0001 USD 0.00
Perrigo Co PLC $149.43 USD -1.41
VIVUS Inc $4.24 USD -0.01
View Industry Companies
 

Industry Analysis

SKB

Industry Average

Valuation SKB Industry Range
Price/Earnings 38.8x
Price/Sales 5.1x
Price/Book 11.3x
Price/Cash Flow 35.3x
TEV/Sales 4.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE CONSUMER HEA, please visit www.gsk-ch.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.